InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by 朱忠远. Officer active across 1 company, notably Duality Biotherapeutics, Inc. - B. Aggregated, 8 disclosures have been published. Activity tracked since 21 May 2026. The latest transaction was disclosed on 3 September 2026 (Purchase). Regulator: HKEX. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
朱忠远 is a declarant and, according to the six filings recorded, a Director of Duality Biotherapeutics, Inc. - B. The most recent filings we hold span 2026-05-27 to 2026-07-02, all in purchases, with total buy volume of EUR 1140705 and no sales.